Palladyne AI Corp. (PDYN) stock intrinsic value fair value estimate & owner earnings analysis

Palladyne AI Corp. (formerly Sarcos Technology and Robotics Corporation, renamed in March 2024) develops AI/ML autonomy software - Palladyne IQ, SwarmOS and Palladyne Pilot - that lets robots, drones and other autonomous systems operate in unstructured environments, sold mainly to U.S. defense and industrial customers. The company had earlier built physical exoskeleton and robotic hardware under the Sarcos name; it has since pivoted to a software-licensing model. In November 2025 it acquired three small aerospace/defense businesses - GuideTech (avionics and engineering services), MKR Fabrication and Warnke Precision Machining - for about $22.6 million, paid mostly in stock, to add engineering and manufacturing capability alongside its software. Because the business changed so fundamentally in 2024, we anchor this valuation on the two fiscal years since the pivot (2024 and 2025) rather than the earlier hardware-era results, which describe a different company. Over those two years the company's operating cash flow, after removing stock-based compensation and working-capital swings, has run at roughly negative $25-31 million a year - it has never generated positive owner earnings in this software-licensing form. Revenue was $7.8 million in 2024 and $5.2 million in 2025 (the 2025 dip was driven in part by a fourth-quarter U.S. government shutdown that delayed contracting and collections), then jumped to $9.3 million in just the first half of 2026 as the newly acquired businesses consolidated for a full period and existing software contracts converted. The company reports a signed and largely funded contract backlog of $13.9 million as of year-end 2025, expected to convert to revenue within about a year; that backlog is the only near-term revenue we treat as secured. Beyond it, management describes its core software products as still in early commercialization with sales cycles it calls unknown, so we do not assume further growth without more evidence. The balance sheet is straightforward: no funded debt, and cash plus short-term investments of roughly $42-47 million as of mid-2026, funded almost entirely by repeated share issuances (about $20 million raised in 2024 and $36 million in 2025) rather than by the business itself - the company has burned through the $217 million in cash it held right after going public in under five years. A small earn-out liability (about $1-2 million) tied to the 2025 acquisitions is the only other debt-like item; it is not material enough to change the picture materially, and it is deducted from cash for these purposes. We therefore value the shares primarily as net cash minus the present value of continuing cash losses, rather than as a stream of profits, since no profitable, self-funding track record exists yet. Base case: operating losses moderate gradually over three years (to roughly $16 million annually by year three) as one-time acquisition-integration costs roll off and the funded backlog converts, consistent with a multi-year pattern of shrinking stock-based compensation since the 2021 listing. Even so, cumulative losses outweigh today's cash cushion, implying further dilutive share issuances - consistent with the company's practice in each of the last several years - and a base-case value modestly below zero per share on today's share count. Bear case: the recent acceleration in cash burn (roughly $40 million annualized in the first half of 2026) continues, the newly acquired businesses prove a drag rather than a complement, and government-contracting delays recur; today's cash cushion is consumed within roughly a year, forcing distressed, highly dilutive financing. Bull case: the backlog converts in full, integration of the 2025 acquisitions goes smoothly, no further government-contracting disruption occurs, and the cost discipline the company has shown since 2021 continues, bringing it to roughly cash-flow breakeven within three years without needing further cash-diluting rescue financing. What would have to be true for the bull case: consistent execution on the existing backlog and newly acquired operations, without a repeat of 2025's government-shutdown-driven revenue disruption or a costly acquisition integration - none of which is yet demonstrated over more than one or two quarters, so we treat it as the upside case rather than the expected one. A reader should note two things. First, the company's 2025 net income (a positive $10.0 million) reflects a large non-cash accounting gain from marking its warrant liabilities to market, not from operations; operating cash flow was still negative $27.6 million that year, and this analysis is built from cash flow, not that net income figure. Second, the company completed a 1-for-6 reverse stock split in July 2023 to maintain its Nasdaq listing after a prolonged share-price decline; this is a purely mechanical historical event that materially changes share counts before and after that date and should not be mistaken for a rescission of debt or a going-concern issue - none is disclosed in the current financial statements, and there is no funded debt. Break-the-case check: the bull case rests partly on the demonstrated multi-year decline in stock-based compensation as evidence of ongoing cost discipline; however, stock-based compensation actually rose from $2.8 million in 2024 to $4.4 million in 2025, driven by new equity awards issued with the November 2025 acquisitions - a specific, dated fact that partially undercuts the cost-discipline story used to support both the base and bull cases, and is reflected in the wider bear-to-bull spread here rather than assumed away.